Correlation Between CERo Therapeutics and 90331HPL1

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CERo Therapeutics and 90331HPL1 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CERo Therapeutics and 90331HPL1 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CERo Therapeutics Holdings and US BANK NATIONAL, you can compare the effects of market volatilities on CERo Therapeutics and 90331HPL1 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CERo Therapeutics with a short position of 90331HPL1. Check out your portfolio center. Please also check ongoing floating volatility patterns of CERo Therapeutics and 90331HPL1.

Diversification Opportunities for CERo Therapeutics and 90331HPL1

0.13
  Correlation Coefficient

Average diversification

The 3 months correlation between CERo and 90331HPL1 is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding CERo Therapeutics Holdings and US BANK NATIONAL in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on US BANK NATIONAL and CERo Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CERo Therapeutics Holdings are associated (or correlated) with 90331HPL1. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of US BANK NATIONAL has no effect on the direction of CERo Therapeutics i.e., CERo Therapeutics and 90331HPL1 go up and down completely randomly.

Pair Corralation between CERo Therapeutics and 90331HPL1

Assuming the 90 days horizon CERo Therapeutics Holdings is expected to generate 27.95 times more return on investment than 90331HPL1. However, CERo Therapeutics is 27.95 times more volatile than US BANK NATIONAL. It trades about 0.19 of its potential returns per unit of risk. US BANK NATIONAL is currently generating about -0.42 per unit of risk. If you would invest  1.28  in CERo Therapeutics Holdings on October 10, 2024 and sell it today you would earn a total of  0.69  from holding CERo Therapeutics Holdings or generate 53.91% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy52.38%
ValuesDaily Returns

CERo Therapeutics Holdings  vs.  US BANK NATIONAL

 Performance 
       Timeline  
CERo Therapeutics 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in CERo Therapeutics Holdings are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, CERo Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
US BANK NATIONAL 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days US BANK NATIONAL has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Bond's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for US BANK NATIONAL investors.

CERo Therapeutics and 90331HPL1 Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CERo Therapeutics and 90331HPL1

The main advantage of trading using opposite CERo Therapeutics and 90331HPL1 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CERo Therapeutics position performs unexpectedly, 90331HPL1 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 90331HPL1 will offset losses from the drop in 90331HPL1's long position.
CERo Therapeutics vs. Nexstar Broadcasting Group
CERo Therapeutics vs. Ryanair Holdings PLC
CERo Therapeutics vs. Constellation Brands Class
CERo Therapeutics vs. flyExclusive,
The idea behind CERo Therapeutics Holdings and US BANK NATIONAL pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
90331HPL1 vs. Siriuspoint
90331HPL1 vs. Conifer Holdings, 975
90331HPL1 vs. First Watch Restaurant
90331HPL1 vs. RCI Hospitality Holdings
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities


 
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY